RENERGEN LIMITED Incorporated in the Republic of South Africa (Registration number: 2014/195093/06) JSE Share code: REN A2X Share code: REN ISIN: ZAE000202610 LEI: 378900B1512179F35A69 Australian Business Number (ABN): 93 998 352 675 ASX Share code: RLT ("Renergen" or "the Company") PHASE 2 FUNDING PROCESS AND POTENTIAL US IPO Renergen is informing shareholders that it is preparing for a potential initial public offering in the United States (IPO) of American Depositary Shares (ADSs) (each representing a number of the Company’s ordinary shares) and listing on the Nasdaq Stock Market in 2023, subject to market and other conditions. In order to raise the requisite equity funding for Phase 2, Renergen is preparing a circular to shareholders wherein Renergen will be seeking approval to issue additional shares by way of a specific issue of shares for cash. The timing, number of ordinary shares represented by ADSs to be offered and their price in the IPO have not yet been determined. Renergen confidentially submitted a draft registration statement on Form F-1 to the Securities and Exchange Commission (SEC) in late 2022. The proposed listing and capital raise is expected to commence after the SEC completes its final review processes, subject to market and other conditions. Shareholders and potential investors should note that the proposed listing and capital raise may or may not proceed. The circular to shareholders is in the process of being reviewed by the JSE and ASX and will be published once all regulatory approvals have been obtained. This announcement is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the Securities Act). This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. Johannesburg 31 January 2023 Authorised by: Stefano Marani Chief Executive Officer Designated Advisor PSG Capital For Australian Investors & Media, contact Citadel-MAGNUS, Cameron Gilenko, 0466 984 953 For South African media queries, contact Mandy Stuart +2784 606 7200 +2710 045 6007 www.renergen.co.za